Say Hello!
Don’t be shy.

   

News

Dr. Gary Allenby and Kathy Dodgson, founders and directors of Aurelia Bioscience, are pleased to announce that after 10 years of success as a standalone biology contract research organisation, the company has been acquired by its collaborator- Charnwood Molecular. To facilitate this agreement, Aurelia Bioscience,...

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, is pleased to announce the acquisition of the assay development and biological screening provider, Aurelia Bioscience. The sector-leading expertise and technology development within Aurelia Bioscience will enable and enhance Charnwood’s provision...

BioCity Nottingham based Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving...

The foremost life science event in the Midlands will be going virtual this year, as Medilink Midlands celebrates its first ever Innovation Day, sponsored by We Are Pioneer Group. Medilink Midlands Innovation Day will be held online on Tuesday 29 June, from 9:00am to 2:00pm. Over...